These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

645 related items for PubMed ID: 1080777

  • 1. IgM antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: the involvement of T and B lymphocytes as effector cells.
    Lamon EW, Whitten HD, Skurzak HM, Andersson B, Lidin B.
    J Immunol; 1975 Nov; 115(5):1288-94. PubMed ID: 1080777
    [Abstract] [Full Text] [Related]

  • 2. Antibody-dependent lymphocyte cytotoxicity in the murine sarcoma virus system: activity of IgM and IgG with specificity for MLV determined antigen(s).
    Lamon EW, Skurzak HM, Andersson B, Whitten HD, Klein E.
    J Immunol; 1975 Apr; 114(4):1171-6. PubMed ID: 1117138
    [Abstract] [Full Text] [Related]

  • 3. Functional activity in vivo of effector T cell populations. III. Protection against Moloney murine sarcoma virus (M-MSV)-induced tumors in T cell deficient mice by the adoptive transfer of a M-MSV-specific cytolytic T lymphocyte clone.
    Cerundolo V, Lahaye T, Horvath C, Zanovello P, Collavo D, Engers HD.
    Eur J Immunol; 1987 Feb; 17(2):173-8. PubMed ID: 3030766
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of proliferation of lymphoma cells and T lymphocytes by suppressor cells from spleens of tumor-bearing mice.
    Kirchner H, Muchmore AV, Chused TM, Holden HT, Herberman RB.
    J Immunol; 1975 Jan; 114(1 Pt 1):206-10. PubMed ID: 122986
    [Abstract] [Full Text] [Related]

  • 5. Generation of cytotoxic T lymphocytes during coxsackievirus tb-3 infection. II. Characterization of effector cells and demonstration cytotoxicity against viral-infected myofibers1.
    Wong CY, Woodruff JJ, Woodruff JF.
    J Immunol; 1977 Apr; 118(4):1165-9. PubMed ID: 300400
    [Abstract] [Full Text] [Related]

  • 6. Cell-mediated immunity to Friend virus-induced leukemia. III. Characteristics of secondary cell-mediated cytotoxic response.
    Ting CC, Kirchner H, Rodrigues D, Park JY, Herberman RB.
    J Immunol; 1976 Jan; 116(1):244-52. PubMed ID: 54388
    [Abstract] [Full Text] [Related]

  • 7. IgM complex receptors on subpopulations of murine lymphocytes.
    Lamon EW, Andersson B, Whitten HD, Hurst MM, Ghanta V.
    J Immunol; 1976 May; 116(5):1199-1203. PubMed ID: 1083866
    [Abstract] [Full Text] [Related]

  • 8. Requirements for T cells in alloantigen-induced generation of non-T cell-mediated cytotoxicity against syngeneic mouse sarcoma cells.
    Paciucci PA, Macphail S, Bach FH, Zarling JM.
    J Immunol; 1980 Jul; 125(1):36-9. PubMed ID: 6155401
    [Abstract] [Full Text] [Related]

  • 9. Cell-mediated cytotoxicity against ectromelia virus-infected target cells. II. Identification of effector cells and analysis of mechanisms.
    Gardner I, Bowern NA, Blanden RV.
    Eur J Immunol; 1974 Feb; 4(2):68-72. PubMed ID: 4546746
    [No Abstract] [Full Text] [Related]

  • 10. Antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: differential activity of IgG and IgM with different subpopulations of lymphocytes.
    Lamon EW, Shaw MW, Goodson S, Lidin B, Walia AS, Fuson EW.
    J Exp Med; 1977 Feb 01; 145(2):302-13. PubMed ID: 833543
    [Abstract] [Full Text] [Related]

  • 11. Antibody-dependent cell-mediated cytotoxicity. Comparative ability of murine Peyer's patch and spleen cells to lyse lipopolysaccharide-coated and uncoated erythrocytes.
    Kagnoff MF, Campbell S.
    Gastroenterology; 1976 Mar 01; 70(3):341-6. PubMed ID: 1082425
    [Abstract] [Full Text] [Related]

  • 12. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice.
    Collavo D, Zanovello P, Biasi G, Chieco-Bianchi L.
    J Immunol; 1981 Jan 01; 126(1):187-93. PubMed ID: 6969741
    [Abstract] [Full Text] [Related]

  • 13. T cell-mediated immunity to oncornavirus-induced tumors. III. Specific and nonspecific suppression in tumor-bearing mice.
    Plater C, Debré P, Leclerc JC.
    Eur J Immunol; 1981 Jan 01; 11(1):39-44. PubMed ID: 6452278
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Immunosuppression by spleen cells from Moloney leukemia. Comparison of the suppressive effect on antibody response and on mitogen-induced response.
    Cerny J, Stiller RA.
    J Immunol; 1975 Oct 01; 115(4):943-9. PubMed ID: 170339
    [Abstract] [Full Text] [Related]

  • 16. Natural cytotoxicity against mouse hepatitis virus-infected cells. II. A cytotoxic effector cell with a B lymphocyte phenotype.
    Welsh RM, Haspel MV, Parker DC, Holmes KV.
    J Immunol; 1986 Feb 15; 136(4):1454-60. PubMed ID: 3003199
    [Abstract] [Full Text] [Related]

  • 17. Secondary cell-mediated cytotoxic response to syngeneic mouse tumor challenge.
    Holden HT, Kirchner H, Herberman RB.
    J Immunol; 1975 Aug 15; 115(2):327-31. PubMed ID: 168259
    [Abstract] [Full Text] [Related]

  • 18. Human antibody-dependent cellular cytotoxicity. Isolation and identification of a subpopulation of peripheral blood lymphocytes which kill antibody-coated autologous target cells.
    Brier AM, Chess L, Schlossman SF.
    J Clin Invest; 1975 Dec 15; 56(6):1580-6. PubMed ID: 53242
    [Abstract] [Full Text] [Related]

  • 19. Suppressor T cells regulate the cytolytic T lymphocyte response to syngeneic tumors induced by murine sarcoma virus (MSV) in the mouse.
    Plata F, MacDonald HR, Shain B.
    J Immunol; 1979 Aug 15; 123(2):852-60. PubMed ID: 156765
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.